Journal of Neuroimmunology
Volume 220, Issue 1 , Pages 99-103 , 30 March 2010

Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis

  • Ruth Dobson

      Affiliations

    • Neuroimmunology Unit, Queen Mary University of London, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, 4 Newark Street, Whitechapel, London E1 2AT, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 207 882 8813; fax: +44 207 377 7033.
    • ,
  • R.F. Miller

      Affiliations

    • Research Department of Infection and Public Health, University College London, London WC1E 6JB, United Kingdom
    • ,
  • H.E. Palmer

      Affiliations

    • Department of Ophthalmology, St Thomas' Hospital, London SW1 7EH, United Kingdom
    • University Hospitals, Birmingham B29 6JD, United Kingdom
    • ,
  • M. Feldmann

      Affiliations

    • Kennedy Institute of Rheumatology, London W6 8LH, United Kingdom
    • ,
  • E.J. Thompson

      Affiliations

    • Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom
    • ,
  • A.J. Thompson

      Affiliations

    • Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom
    • ,
  • D.H. Miller

      Affiliations

    • Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom
    • ,
  • G. Giovannoni

      Affiliations

    • Neuroimmunology Unit, Queen Mary University of London, Blizard Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, 4 Newark Street, Whitechapel, London E1 2AT, United Kingdom
    • Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom

Received 30 October 2009 ,Revised 4 January 2010 ,Accepted 20 January 2010.

References 

  1. Arnett F, Edworthy S, Bloch D, Mcshane D, Fries J, Cooper N, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324
  2. Cooper A, Bluestone R. Free immunoglobulin light chains in connective tissue diseases. Ann. Rheum. Dis. 1968;27:537–543
  3. Cotton F, Weiner H, Jolesz F, Guttmann C. MRI contrast uptake in new lesions in relapsing–remitting MS followed at weekly intervals. Neurology. 2003;60:640–646
  4. De Milito A, Nilsson A, Titanji K, Thorstensson R, Reizenstein E, Narita M, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood. 2004;103:2180–2186
  5. Elovaara I, Seppälä I, Kinnunen E, Laaksovirta H. Increased occurrence of free immunoglobulin light chains in cerebrospinal fluid and serum in human immunodeficiency virus-1 infection. J. Neuroimmunol. 1991;35:65–77
  6. Felson D, Anderson J, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993;36:729–740
  7. Filomena C. Oligoclonal banding detected by urinary protein electrophoresis and immunofixation in two patients with the acquired immune deficiency syndrome and proteinuria. Clin. Chem. 1989;35:1795–1798
  8. Franciotta D, Salvetti M, Lolli F, Serafini B, Aloisi F. B cells and multiple sclerosis. Lancet Neurol. 2008;7:852–858
  9. Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch. Neurol. 2005;62:865–870
  10. Ghose T, Quigley J, Landrigan P, Asif A. Immunoglobulins in aqueous humour and iris from patients with endogenous uveitis and patients with cataract. Br. J. Ophthalmol. 1973;57:897–903
  11. Giovannoni G, Heales S, Silver N, O'riordan J, Miller R, Land J, et al. Raised serum nitrate and nitrite levels in patients with multiple sclerosis. J. Neurol. Sci. 1997;145:77–81
  12. Giovannoni G, Silver N, O'riordan J, Miller R, Heales S, Land J, et al. Increased urinary nitric oxide metabolites in patients with multiple sclerosis correlates with early and relapsing disease. Mult. Scler. 1999;5:335–341
  13. Giovannoni G, Silver N, Good C, Miller D, Thompson E. Immunological time-course of gadolinium-enhancing MRI lesions in patients with multiple sclerosis. Eur. Neurol. 2000;44:222–228
  14. Hauser S, Waubant E, Arnold D, Vollmer T, Antel J, Fox R, et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 2008;358:676–688
  15. Ingle G, Sastre-Garriga J, Miller D, Thompson A. Is inflammation important in early PPMS? A longitudinal MRI study. J. Neurol. Neurosurg. Psychiatry. 2005;76:1255–1258
  16. Kahn S. Urinary “oligoclonal” bands in AIDS. Clin. Chem. 1990;36:174–175
  17. Kappos L, Moeri D, Radue E, Schoetzau A, Schweikert K, Barkhof F, et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group. Lancet. 1999;353:964–969
  18. Kelly C, Baird G, Foster H, Hosker H, Griffiths I. Prognostic significance of paraproteinaemia in rheumatoid arthritis. Ann. Rheum. Dis. 1991;50:290–294
  19. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–1452
  20. Lublin F, Reingold S. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996;46:907–911
  21. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007;130:1089–1104
  22. McFarland H. The B cell—old player, new position on the team. N. Engl. J. Med. 2008;358:664–665
  23. Mehta P, Cook S, Troiano R, Coyle P. Increased free light chains in the urine from patients with multiple sclerosis. Neurology. 1991;41:540–544
  24. Miller D, Albert P, Barkhof F, Francis G, Frank J, Hodgkinson S, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann. Neurol. 1996;39:6–16
  25. Murray P, Hoekzema R, Luyendijk L, Konings S, Kijlstra A. Analysis of aqueous humor immunoglobulin G in uveitis by enzyme-linked immunosorbent assay, isoelectric focusing, and immunoblotting. Invest. Ophthalmol. Vis. Sci. 1990;31:2129–2135
  26. Pezzoli A, Pascali E. Bence Jones proteinuria in multiple sclerosis. Clin. Chem. 1987;33:1923–1924
  27. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 1983;13:227–231
  28. Presslauer S, Milosavljevic D, Brücke T, Bayer P, Hübl W. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis. J. Neurol. 2008;255:1508–1514
  29. Rinker JN, Trinkaus K, Cross A. Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis. Neurology. 2006;67:1288–1290
  30. Rudick R, Peter D, Bidlack J, Knutson D. Multiple sclerosis: free light chains in cerebrospinal fluid. Neurology. 1985;35:1443–1449
  31. Sormani, M., Rovaris, M., Comi, G., Filippi, M. 2009. A reassessment of the plateauing relationship between T2 lesion load and disability in MS. Neurology.
  32. Tintore M, Rovira A, Rio J, Tur C, Pelayo R, Nos C, et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis. Neurology. 2008;13(2):1079–1083
  33. Tsai C, Wu T, Sun K, Lin W, Yu C. Increased excretion of soluble interleukin 2 receptors and free light chain immunoglobulins in the urine of patients with active lupus nephritis. Ann. Rheum. Dis. 1992;51:168–172

PII: S0165-5728(10)00017-2

doi: 10.1016/j.jneuroim.2010.01.012

Journal of Neuroimmunology
Volume 220, Issue 1 , Pages 99-103 , 30 March 2010

Article Tools

* Image Usage & Resolution